170 related articles for article (PubMed ID: 6549047)
21. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
Schwab M
Verh Dtsch Ges Pathol; 1994; 78():26-33. PubMed ID: 7533996
[TBL] [Abstract][Full Text] [Related]
22. Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow sorting of metaphase chromosomes.
Kanda N; Schreck R; Alt F; Bruns G; Baltimore D; Latt S
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4069-73. PubMed ID: 6575396
[TBL] [Abstract][Full Text] [Related]
23. Amplification and expression of the c-myc oncogene in human lung cancer cell lines.
Little CD; Nau MM; Carney DN; Gazdar AF; Minna JD
Nature; 1983 Nov 10-16; 306(5939):194-6. PubMed ID: 6646201
[TBL] [Abstract][Full Text] [Related]
24. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.
Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros PF; Kovar H; Thoraval D; Motyka S; Alberts JR; Hanash SM
Oncogene; 1999 Jan; 18(1):233-8. PubMed ID: 9926938
[TBL] [Abstract][Full Text] [Related]
25. Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
Gnatt A; Prody CA; Zamir R; Lieman-Hurwitz J; Zakut H; Soreq H
Cancer Res; 1990 Apr; 50(7):1983-7. PubMed ID: 2317787
[TBL] [Abstract][Full Text] [Related]
26. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.
Longo L; Christiansen H; Christiansen NM; Cornaglia-Ferraris P; Lampert F
J Cancer Res Clin Oncol; 1988; 114(6):636-40. PubMed ID: 3204111
[TBL] [Abstract][Full Text] [Related]
27. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
[TBL] [Abstract][Full Text] [Related]
28. Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences.
Hunt JD; Valentine M; Tereba A
Mol Cell Biol; 1990 Feb; 10(2):823-9. PubMed ID: 2405257
[TBL] [Abstract][Full Text] [Related]
29. Increased N-myc expression following progressive growth of human neuroblastoma.
Rosen N; Reynolds CP; Thiele CJ; Biedler JL; Israel MA
Cancer Res; 1986 Aug; 46(8):4139-42. PubMed ID: 3731081
[TBL] [Abstract][Full Text] [Related]
30. Characterization of DNA rearrangements of N-myc gene amplification in three neuroblastoma cell lines by pulsed-field gel electrophoresis.
Kato H; Okamura K; Kurosawa Y; Kishikawa T; Hashimoto K
FEBS Lett; 1989 Jul; 250(2):529-35. PubMed ID: 2753147
[TBL] [Abstract][Full Text] [Related]
31. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization.
McRobert TL; Rudduck C; Kees UR; Garson OM
Cancer Genet Cytogenet; 1992 Apr; 59(2):128-34. PubMed ID: 1581879
[TBL] [Abstract][Full Text] [Related]
32. Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization.
Cohen PS; Seeger RC; Triche TJ; Israel MA
Am J Pathol; 1988 Jun; 131(3):391-7. PubMed ID: 2454580
[TBL] [Abstract][Full Text] [Related]
33. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
34. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
[TBL] [Abstract][Full Text] [Related]
35. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.
Schwab M; Alitalo K; Varmus HE; Bishop JM; George D
Nature; 1983 Jun 9-15; 303(5917):497-501. PubMed ID: 6304530
[TBL] [Abstract][Full Text] [Related]
36. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications.
Brodeur GM; Seeger RC
Cancer Genet Cytogenet; 1986 Jan; 19(1-2):101-11. PubMed ID: 3940169
[TBL] [Abstract][Full Text] [Related]
37. Human neuroblastoma cell lines that express N-myc without gene amplification.
Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression.
Amatruda TT; Sidell N; Ranyard J; Koeffler HP
Biochem Biophys Res Commun; 1985 Feb; 126(3):1189-95. PubMed ID: 3977910
[TBL] [Abstract][Full Text] [Related]
39. Studies on the expression of the amplified domain in human neuroblastoma cells.
Melera PW; Michitsch RW; Montgomery KT; Biedler JL; Scotto KW; Davide JP
Prog Clin Biol Res; 1985; 175():115-29. PubMed ID: 3991727
[No Abstract] [Full Text] [Related]
40. Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences.
Brennand J; Chinault AC; Konecki DS; Melton DW; Caskey CT
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1950-4. PubMed ID: 6952245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
